Assessing the Influence of B‐US , CDFI , SE, and Patient Age on Predicting Molecular Subtypes in Breast Lesions Using Deep Learning Algorithms
Journal of Ultrasound in Medicine · 2024
DOI: 10.1002/jum.16460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, 2024. Verfasst von Weiyong Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Chin…. Hauptthemen laut MEDLINE: Deep Learning, Breast Neoplasms, Ultrasonography, Mammary, Elasticity Imaging Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Medical Artificial Intelligence Joint Fund Project.
Abstract (Originalsprache)
Objectives
Our study aims to investigate the impact of B‐mode ultrasound (B‐US) imaging, color Doppler flow imaging (CDFI), strain elastography (SE), and patient age on the prediction of molecular subtypes in breast lesions.
Methods
Totally 2272 multimodal ultrasound imaging was collected from 198 patients. The ResNet‐18 network was employed to predict four molecular subtypes from B‐US imaging, CDFI, and SE of patients with different ages. All the images were split into training and testing datasets by the ratio of 80%:20%. The predictive performance on testing dataset was evaluated through 5 metrics including mean accuracy, precision, recall, F1‐scores, and confusion matrix.
Results
Based on B‐US imaging, the test mean accuracy is 74.50%, the precision is 74.84%, the recall is 72.48%, and the F1‐scores is 0.73. By combining B‐US imaging with CDFI, the results were increased to 85.41%, 85.03%, 85.05%, and 0.84, respectively. With the integration of B‐US imaging and SE, the results were changed to 75.64%, 74.69%, 73.86%, and 0.74, respectively. Using images from patients under 40 years old, the results were 90.48%, 90.88%, 88.47%, and 0.89. When images from patients who are above 40 years old, they were changed to 81.96%, 83.12%, 80.5%, and 0.81, respectively.
Conclusion
Multimodal ultrasound imaging can be used to accurately predict the molecular subtypes of breast lesions. In addition to B‐US imaging, CDFI rather than SE contribute further to improve predictive performance. The predictive performance is notably better for patients under 40 years old compared with those who are 40 years old and above.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- School of Management, Hefei University of Technology, Hefei, China.
- Key Laboratory of Process Optimization and Intelligent Decision-Making, Ministry of Education, Hefei, China.
- Ministry of Education Engineering Research Center for Intelligent Decision-Making & Information System Technologies, Hefei, China.
- Reliable Intelligence and Medical Innovation Laboratory (RIMI Lab), Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.
ORCID-Profile: Weiyong Liu
Förderung
- Medical Artificial Intelligence Joint Fund Project
Zitieren
APA
Liu, W., Wang, D., Liu, L., & Zhou, Z. (2024). Assessing the Influence of B‐US , CDFI , SE, and Patient Age on Predicting Molecular Subtypes in Breast Lesions Using Deep Learning Algorithms. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16460
Vancouver
Liu W, Wang D, Liu L, Zhou Z. Assessing the Influence of B‐US , CDFI , SE, and Patient Age on Predicting Molecular Subtypes in Breast Lesions Using Deep Learning Algorithms. Journal of Ultrasound in Medicine. 2024. doi:10.1002/jum.16460
BibTeX
@article{Liu2024,
author = {Liu, Weiyong and Wang, Dongyue and Liu, Le and Zhou, Zhiguo},
title = {Assessing the Influence of B‐US , CDFI , SE, and Patient Age on Predicting Molecular Subtypes in Breast Lesions Using Deep Learning Algorithms},
journal = {Journal of Ultrasound in Medicine},
year = {2024},
doi = {10.1002/jum.16460}
}
EUVIMED